Hospira says saline recall will not make shortage worse

Hospira ($HSP), the country's largest producer of sterile drugs, is recalling two dozen lots of saline solution, along with 30 lots of other products, because the bags on one of its delivery systems can leak and products might get contaminated. The recall of the saline comes in the midst of a national shortage, but the Lake Forest, IL-based company insists the recall should not make the shortage worse. It said it believed most of the lots had been used already after Hospira warned providers to check bags closely to make sure they were undamaged and the saline was clear. Story | More

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.